[RGLS] QoQ Quarter Result on 30-Sep-2023 [#Q3]

Stock
[RGLS] Regulus Therapeutics Inc.
Announcement Date
09-Nov-2023
Financial Year
2023
Quarter
30-Sep-2023 [#Q3]
Profit Trend
QoQ- -11.56%
YoY- -3.78%
Quarter Report
RGLS's Result
RGLS's Financial Summary
View:
Show?
Quarter Result
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
Revenue 0 0 302 0 0 0 0 -
PBT -11,035 -8,469 -8,061 -7,824 -7,012 -7,139 -6,795 38.20%
Tax 1 -81 100 -56 1 -45 1 0.00%
NP -11,036 -8,469 -8,061 -7,824 -7,013 -7,094 -6,796 38.19%
Tax Rate - - - - - - - -
Total Cost 11,036 8,469 8,363 7,824 7,013 7,094 6,796 38.19%
Ratio Analysis
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
NP Margin 0.00 0.00 -2,669.21 0.00 0.00 0.00 0.00 -
Per Share
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
EPS -0.17 -0.29 -0.40 -0.40 -0.37 -0.42 -0.40 -43.50%
EPS Diluted -0.17 -0.29 -0.40 -0.40 -0.37 -0.42 -0.40 -43.50%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.